Neurocrine Biosciences: Q3 Earnings Insights

Neurocrine Biosciences NBIX reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences beat estimated earnings by 35.0%, reporting an EPS of $1.08 versus an estimate of $0.8.

Revenue was up $91.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.25 which was followed by a 8.45% increase in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.